1  (0.5 days vs 2.1 days, p=0.0006) with fewer loose stools (3.7 vs 10.5, p<0.0001) than placebo.

2 particular symptoms (stomach pain, fainting, loose stools/diarrhea, palpitations, and sleep problems)

3 rrheal illness <7 d duration comprising >/=3 loose stools in 24 h and >/=1 of the following: sunken e

4 (defined as maternal report of three or more loose stools in 24 h, or one loose stool with visible bl

5        Diarrhoea was graded by the number of loose stools in 24 h: mild (three), moderate (four or fi

6  years old, hospitalized with diarrhea (>/=3 loose stools in 24 hours) at two district hospitals in N

7 l pain and bloating scores of 3 or more, and loose stool, located at 270 centers in the United States

8 from baseline and a decrease in frequency of loose stools of >/=50% from baseline, for 2 or more week

9 oup reductions in abdominal pain (p < 0.01), loose stools (p < 0.01), bloating (p < 0.05), flatulence

10 e diarrhoea (defined by WHO as three or more loose stools per day for less than 14 days).

11 ossibility when the patient has fewer than 3 loose stools per day; the glutamate dehydrogenase test f

12 with chronic diarrhea, defined as passage of loose stools three or more times per week for 6 months,

13 lated gastrointestinal side effects (nausea, loose stools, vomiting) were common but did not limit th

14            Secondary hyperparathyroidism and loose stools were more frequent after distal gastric byp

15 f three or more loose stools in 24 h, or one loose stool with visible blood) were identified through

16 s return, he developed diarrhea, cramps, and loose stools without blood or mucus in the absence of fe